216 related articles for article (PubMed ID: 19052516)
1. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers.
Fetterolf DE; Istwan NB; Stanziano GJ
Manag Care; 2014 Jul; 23(7):31-8. PubMed ID: 25199368
[No Abstract] [Full Text] [Related]
3. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.
Langer A; Rogowski W
BMC Health Serv Res; 2009 Jul; 9():115. PubMed ID: 19591680
[TBL] [Abstract][Full Text] [Related]
4. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
Karr JC
Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
[TBL] [Abstract][Full Text] [Related]
6. Innovative therapies in wound healing.
Shen JT; Falanga V
J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
Cazzell S
Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
[TBL] [Abstract][Full Text] [Related]
8. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
Gibbs S; van den Hoogenband HM; de Boer EM
Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
[TBL] [Abstract][Full Text] [Related]
9. The FDA and designing clinical trials for chronic cutaneous ulcers.
Maderal AD; Vivas AC; Eaglstein WH; Kirsner RS
Semin Cell Dev Biol; 2012 Dec; 23(9):993-9. PubMed ID: 23063664
[TBL] [Abstract][Full Text] [Related]
10. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers.
Stone RC; Stojadinovic O; Rosa AM; Ramirez HA; Badiavas E; Blumenberg M; Tomic-Canic M
Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053158
[TBL] [Abstract][Full Text] [Related]
11. A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers.
Harding K; Sumner M; Cardinal M
Int Wound J; 2013 Apr; 10(2):132-7. PubMed ID: 23506344
[TBL] [Abstract][Full Text] [Related]
12. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.
Zaulyanov L; Kirsner RS
Clin Interv Aging; 2007; 2(1):93-8. PubMed ID: 18044080
[TBL] [Abstract][Full Text] [Related]
13. Current Available Cellular and Tissue-Based Products for Treatment of Skin Defects.
Liu Y; Panayi AC; Bayer LR; Orgill DP
Adv Skin Wound Care; 2019 Jan; 32(1):19-25. PubMed ID: 30570555
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of low-frequency ultrasound as an added treatment for chronic wounds: A meta-analysis.
Chen H; Yu Z; Liu N; Huang J; Liang X; Liang X; Liang M; Li M; Ni J
Int Wound J; 2023 Feb; 20(2):448-457. PubMed ID: 35855676
[TBL] [Abstract][Full Text] [Related]
15. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
Saap LJ; Donohue K; Falanga V
Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
[TBL] [Abstract][Full Text] [Related]
16. A review of bioactive materials and chronic wounds.
Plotner AN; Mostow EN
Cutis; 2010 May; 85(5):259-66. PubMed ID: 20540417
[TBL] [Abstract][Full Text] [Related]
17. Combining bioengineered human dermal replacement and multilayered compression dressings to manage ulcers in a person with diabetes mellitus: a case study.
Angirasa AK; Willrich A; Cooper B; Stuck R
Ostomy Wound Manage; 2006 May; 52(5):60-4. PubMed ID: 16687770
[TBL] [Abstract][Full Text] [Related]
18. The chronic non-healing wound: how to make it better.
Grey JE; Harding KG
Hosp Med; 1998 Jul; 59(7):557-63. PubMed ID: 9798546
[TBL] [Abstract][Full Text] [Related]
19. Failure rates of artificial dermis products in treatment of diabetic foot ulcer: A systematic review and network meta-analysis.
Tchero H; Herlin C; Bekara F; Kangambega P; Sergiu F; Teot L
Wound Repair Regen; 2017 Aug; 25(4):691-696. PubMed ID: 28597935
[TBL] [Abstract][Full Text] [Related]
20. Bioengineered skin in diabetic foot ulcers.
Teng YJ; Li YP; Wang JW; Yang KH; Zhang YC; Wang YJ; Tian JH; Ma B; Wang JM; Yan X
Diabetes Obes Metab; 2010 Apr; 12(4):307-15. PubMed ID: 20380651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
